BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 16882274)

  • 1. Interpreting trends in cancer patient survival.
    Dickman PW; Adami HO
    J Intern Med; 2006 Aug; 260(2):103-17. PubMed ID: 16882274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An alternative approach to monitoring cancer patient survival.
    Brenner H; Gefeller O
    Cancer; 1996 Nov; 78(9):2004-10. PubMed ID: 8909323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries.
    Gondos A; Bray F; Brewster DH; Coebergh JW; Hakulinen T; Janssen-Heijnen ML; Kurtinaitis J; Brenner H;
    Eur J Cancer; 2008 Jul; 44(10):1463-75. PubMed ID: 18455387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.
    Karim-Kos HE; de Vries E; Soerjomataram I; Lemmens V; Siesling S; Coebergh JW
    Eur J Cancer; 2008 Jul; 44(10):1345-89. PubMed ID: 18280139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interpreting cancer trends.
    Ward EM; Thun MJ; Hannan LM; Jemal A
    Ann N Y Acad Sci; 2006 Sep; 1076():29-53. PubMed ID: 17119192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthy screened bias in epidemiologic studies of cancer incidence.
    Weiss NS; Rossing MA
    Epidemiology; 1996 May; 7(3):319-22. PubMed ID: 8728451
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of cervical screening history data to interpret cervical cancer incidence trends.
    Clare J; Edwards D; Bagnall H; Pearmain P; Lawrence G
    J Public Health (Oxf); 2008 Jun; 30(2):171-7. PubMed ID: 18296455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SURVSOFT-Software for nonparametric survival analysis.
    Geiss K; Meyer M; Radespiel-Tröger M; Gefeller O
    Comput Methods Programs Biomed; 2009 Oct; 96(1):63-71. PubMed ID: 19443077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimating lead time and overdiagnosis associated with PSA screening from prostate cancer incidence trends.
    Telesca D; Etzioni R; Gulati R
    Biometrics; 2008 Mar; 64(1):10-9. PubMed ID: 17501937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in area-socioeconomic and race-ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987-2005).
    Harper S; Lynch J; Meersman SC; Breen N; Davis WW; Reichman MC
    Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):121-31. PubMed ID: 19124489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International comparisons of survival from lung cancer: pitfalls and warnings.
    Erridge SC; Møller H; Price A; Brewster D
    Nat Clin Pract Oncol; 2007 Oct; 4(10):570-7. PubMed ID: 17898807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thriving for clues in variations seen in mortality and incidence of cancer: geographic patterns, temporal trends, and human population diversities in cancer incidence and mortality.
    Mosavi-Jarrahi A; Mohagheghi MA
    Methods Mol Biol; 2009; 471():137-59. PubMed ID: 19109778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating survival in newly diagnosed cancer patients: use of computer simulations to evaluate performances of different approaches in a wide range of scenarios.
    Rashid I; Marcheselli L; Federico M
    Stat Med; 2008 May; 27(12):2145-58. PubMed ID: 18095273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncompliance in cancer screening trials.
    Gareen IF
    Clin Trials; 2007; 4(4):341-9. PubMed ID: 17848495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [What rate of cure for cancer?].
    Hill C
    Bull Cancer; 1998 Sep; 85(9):745-6. PubMed ID: 9817057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in the incidence and survival of cancer in teenagers and young adults: regional analysis for South East England 1960-2002.
    Croucher C; Whelan JS; Møller H; Davies EA
    Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):417-24. PubMed ID: 19375901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer in children and adolescents in Europe: developments over 20 years and future challenges.
    Pritchard-Jones K; Kaatsch P; Steliarova-Foucher E; Stiller CA; Coebergh JW
    Eur J Cancer; 2006 Sep; 42(13):2183-90. PubMed ID: 16919780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cure of cancer: a European perspective.
    Francisci S; Capocaccia R; Grande E; Santaquilani M; Simonetti A; Allemani C; Gatta G; Sant M; Zigon G; Bray F; Janssen-Heijnen M;
    Eur J Cancer; 2009 Apr; 45(6):1067-79. PubMed ID: 19131242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modelling relative survival using transformation methods.
    Price DL; Manatunga AK
    Stat Med; 2004 Aug; 23(15):2463-77. PubMed ID: 15273959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.